Literature DB >> 11940758

Early albumin infusion improves global and local hemodynamics and reduces inflammatory response in hemorrhagic shock.

Georg Horstick1, Michael Lauterbach, Tibor Kempf, Sucharit Bhakdi, Axel Heimann, Marina Horstick, Jürgen Meyer, Oliver Kempski.   

Abstract

OBJECTIVE: To evaluate the effects of an early, short-term albumin infusion on mesenteric microcirculation and global hemodynamics in hemorrhagic shock.
DESIGN: A prospective, randomized study.
SETTING: Animal laboratory at a university medical clinic.
SUBJECTS: Seventeen Sprague-Dawley rats weighing 250-400 g.
INTERVENTIONS: The rats underwent median laparotomy and exteriorization of an ileal loop for intravital microscopy of the mesenteric microcirculation. Volume-controlled hemorrhagic shock was provoked by arterial blood withdrawal (2.5 mL/100 g body weight for 60 mins), followed by a 4-hr reperfusion period. Albumin (20%) or 0.9% NaCl was administered intravenously as a continuous infusion for 30 mins at the beginning of reperfusion. Reperfusion time mimicked a "prehospital" phase of 30 mins followed by a quasi "in-hospital" phase of 3.5 hrs. The "in-hospital" phase in both groups was initiated by substitution of blood followed by reperfusion with normal saline.
MEASUREMENTS AND MAIN RESULTS: Central hemodynamics, mesenteric microcirculation, and arterial blood gas parameters were monitored before, during, and 60 mins after hemorrhagic shock, and for a 240-min follow-up period after initiation of reperfusion. Application of albumin markedly reduced rolling and adherent leukocytes, maximum velocity, and shear rate in the mesenteric microcirculation. Later, after improvement of mesenteric microcirculation, an intermittent increase of central venous pressure and abdominal blood flow and decrease of hematocrit was observed.
CONCLUSIONS: Albumin treatment of hemorrhagic shock improves microcirculation and global hemodynamics and attenuates the inflammatory response to reperfusion. It may provide clinical benefit when applied at an early stage of reperfusion during hemorrhagic shock.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11940758     DOI: 10.1097/00003246-200204000-00023

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  20 in total

1.  The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes.

Authors:  Jose I Suarez; Renee H Martin; Eusebia Calvillo; Catherine Dillon; Eric M Bershad; R Loch Macdonald; John Wong; Robert Harbaugh
Journal:  Stroke       Date:  2012-01-19       Impact factor: 7.914

2.  Cerebral Vasospasm in Critically III Patients with Aneurysmal Subarachnoid Hemorrhage: Does the Evidence Support the Ever-Growing List of Potential Pharmacotherapy Interventions?

Authors:  Tyree H Kiser
Journal:  Hosp Pharm       Date:  2014-11

3.  Pharmacologic Options for Prevention and Management of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage.

Authors:  Tyree H Kiser
Journal:  Hosp Pharm       Date:  2013-09-01

4.  Albumin resuscitation protects against traumatic/hemorrhagic shock-induced lung apoptosis in rats.

Authors:  Yun Zhang; Zhong-Yan Liang; Shao-Yang Zhang; Fang-Fang Huang; Wei Wu; Yuan Gao; Zuo-Bing Chen
Journal:  J Zhejiang Univ Sci B       Date:  2008-11       Impact factor: 3.066

5.  Greater cardiac response of colloid than saline fluid loading in septic and non-septic critically ill patients with clinical hypovolaemia.

Authors:  Ronald J Trof; Sharwan P Sukul; Jos W R Twisk; Armand R J Girbes; A B Johan Groeneveld
Journal:  Intensive Care Med       Date:  2010-02-18       Impact factor: 17.440

6.  Albumin protects against gut-induced lung injury in vitro and in vivo.

Authors:  Adena J Osband; Edwin A Deitch; Carl J Hauser; Qi Lu; Sergey Zaets; Tamara Berezina; George W Machiedo; Kapil K Rajwani; Da-Zhong Xu
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

Review 7.  Prevention of acute kidney injury and protection of renal function in the intensive care unit. Expert opinion of the Working Group for Nephrology, ESICM.

Authors:  Michael Joannidis; Wilfred Druml; Lui G Forni; A B Johan Groeneveld; Patrick Honore; Heleen M Oudemans-van Straaten; Claudio Ronco; Marie R C Schetz; Arend Jan Woittiez
Journal:  Intensive Care Med       Date:  2010-03       Impact factor: 17.440

8.  Clinical strategies for supporting the untransfusable hemorrhaging patient.

Authors:  Gavin M Melmed; Meredith E Hulsey; Mike Newhouse; Houston E Holmes; Edward J Mays
Journal:  Proc (Bayl Univ Med Cent)       Date:  2009-10

9.  Key Controversies in Colloid and Crystalloid Fluid Utilization.

Authors:  Erin N Frazee; David D Leedahl; Kianoush B Kashani
Journal:  Hosp Pharm       Date:  2015-06

Review 10.  Fluid resuscitation: past, present, and the future.

Authors:  Heena P Santry; Hasan B Alam
Journal:  Shock       Date:  2010-03       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.